Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health. 

Re-evaluation by the second look algorithm could result in a cancer diagnosis up to one year earlier, especially for high risk disease.

Experts believe the tool has “excellent” potential to help guide decisions during labor and delivery in the future.

Screening uptake for younger women has been steadily rising for years. Consequently, so have cancer rates among the population. 

The shorter stay doesn't come at the expense of increased post-procedural complications, authors of a new analysis in JVIR recently shared.

It has long been believed that hormone therapy could have neuroprotective effects on the brain. However, new data suggests that this isn't the case for every woman.